318 related articles for article (PubMed ID: 32361484)
1. Neurotoxicity of antineoplastic drugs: Mechanisms, susceptibility, and neuroprotective strategies.
Pellacani C; Eleftheriou G
Adv Med Sci; 2020 Sep; 65(2):265-285. PubMed ID: 32361484
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies.
Beijers AJ; Jongen JL; Vreugdenhil G
Neth J Med; 2012 Jan; 70(1):18-25. PubMed ID: 22271810
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies.
Park SB; Krishnan AV; Lin CS; Goldstein D; Friedlander M; Kiernan MC
Curr Med Chem; 2008; 15(29):3081-94. PubMed ID: 19075655
[TBL] [Abstract][Full Text] [Related]
4. Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective approaches.
Screnci D; McKeage MJ
J Inorg Biochem; 1999 Oct; 77(1-2):105-10. PubMed ID: 10626361
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
Bianchi R; Brines M; Lauria G; Savino C; Gilardini A; Nicolini G; Rodriguez-Menendez V; Oggioni N; Canta A; Penza P; Lombardi R; Minoia C; Ronchi A; Cerami A; Ghezzi P; Cavaletti G
Clin Cancer Res; 2006 Apr; 12(8):2607-12. PubMed ID: 16638873
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced peripheral neurotoxicity: a critical analysis.
Park SB; Goldstein D; Krishnan AV; Lin CS; Friedlander ML; Cassidy J; Koltzenburg M; Kiernan MC
CA Cancer J Clin; 2013; 63(6):419-37. PubMed ID: 24590861
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-induced peripheral neurotoxicity.
Cavaletti G; Marmiroli P
Expert Opin Drug Saf; 2004 Nov; 3(6):535-46. PubMed ID: 15500413
[TBL] [Abstract][Full Text] [Related]
8. [Neurotoxicity and dermatologic toxicity of cancer chemotherapy].
Nakane M
Gan To Kagaku Ryoho; 2006 Jan; 33(1):29-33. PubMed ID: 16410694
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of oxaliplatin neurotoxicity by drugs in humans and experimental animals: a minireview of recent literature.
Ali BH
Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):272-9. PubMed ID: 20050845
[TBL] [Abstract][Full Text] [Related]
10. Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management.
Verstappen CC; Heimans JJ; Hoekman K; Postma TJ
Drugs; 2003; 63(15):1549-63. PubMed ID: 12887262
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-induced neuropathies-a growing problem for patients and health care providers.
Banach M; Juranek JK; Zygulska AL
Brain Behav; 2017 Jan; 7(1):e00558. PubMed ID: 28127506
[TBL] [Abstract][Full Text] [Related]
12. The role of oxidative stress and anti-oxidant treatment in platinum-induced peripheral neurotoxicity.
Carozzi VA; Marmiroli P; Cavaletti G
Curr Cancer Drug Targets; 2010 Nov; 10(7):670-82. PubMed ID: 20578989
[TBL] [Abstract][Full Text] [Related]
13. Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview.
Chan A; Hertz DL; Morales M; Adams EJ; Gordon S; Tan CJ; Staff NP; Kamath J; Oh J; Shinde S; Pon D; Dixit N; D'Olimpio J; Dumitrescu C; Gobbo M; Kober K; Mayo S; Pang L; Subbiah I; Beutler AS; Peters KB; Loprinzi C; Lustberg MB
Support Care Cancer; 2019 Oct; 27(10):3729-3737. PubMed ID: 31363906
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.
Argyriou AA; Bruna J; Marmiroli P; Cavaletti G
Crit Rev Oncol Hematol; 2012 Apr; 82(1):51-77. PubMed ID: 21908200
[TBL] [Abstract][Full Text] [Related]
15. Cancer-treatment-induced neurotoxicity--focus on newer treatments.
Stone JB; DeAngelis LM
Nat Rev Clin Oncol; 2016 Feb; 13(2):92-105. PubMed ID: 26391778
[TBL] [Abstract][Full Text] [Related]
16. Neuronal drug transporters in platinum drugs-induced peripheral neurotoxicity.
Cavaletti G; Ceresa C; Nicolini G; Marmiroli P
Anticancer Res; 2014 Jan; 34(1):483-6. PubMed ID: 24403505
[TBL] [Abstract][Full Text] [Related]
17. Toxic neuropathy.
Umapathi T; Chaudhry V
Curr Opin Neurol; 2005 Oct; 18(5):574-80. PubMed ID: 16155443
[TBL] [Abstract][Full Text] [Related]
18. Platinum-induced neurotoxicity and preventive strategies: past, present, and future.
Avan A; Postma TJ; Ceresa C; Avan A; Cavaletti G; Giovannetti E; Peters GJ
Oncologist; 2015 Apr; 20(4):411-32. PubMed ID: 25765877
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup.
Kerckhove N; Busserolles J; Stanbury T; Pereira B; Plence V; Bonnetain F; Krakowski I; Eschalier A; Pezet D; Balayssac D
BMJ Open; 2019 Jun; 9(6):e027770. PubMed ID: 31182448
[TBL] [Abstract][Full Text] [Related]
20. Central and peripheral nervous system toxicity of common chemotherapeutic agents.
Sioka C; Kyritsis AP
Cancer Chemother Pharmacol; 2009 Apr; 63(5):761-7. PubMed ID: 19034447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
